STRATEC SE

Declaration of Voting Results & Voting Rights Announcements • Oct 8, 2014

News Details

Voting Rights Announcements | 8 October 2014 14:26

Correction of a release from 23.05.2013, 11:40 CET – STRATEC Biomedical AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

STRATEC Biomedical AG

08.10.2014 14:26

Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

---

Correction of release dated 23 May 2013

1. Threadneedle Asset Management Holdings Limited

On 6 October 2014 Threadneedle Asset Management Holdings Limited, London,
UK, has sent us the following correction of their voting rights
notification dated 22 May 2013:

Threadneedle Asset Management Holdings Limited, London, UK, has notified us
pursuant to sec. 21 para. 1 WpHG, that on 18 April 2013 the share of voting
rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN: DE0007289001
went above the threshold of 5% and that the percentage of voting rights on
that day amounted to 5.35% (628,462 voting rights). Threadneedle Asset
Management Holdings Limited has notified us that these voting rights of
5.35% (628,462 voting rights) are attributable to Threadneedle Asset
Management Holdings Limited pursuant to sec. 22 para. 1 sent. 1 no. 6 in
connection with sent. 2 WpHG.

The voting rights were attributed to Threadneedle Asset Management Holdings
Limited inter alia from Threadneedle Investment Funds ICVC, being a
shareholder holding 3% or more of the voting rights in STRATEC Biomedical
AG.

1. Threadneedle Asset Management Limited

On 6 October 2014 Threadneedle Asset Management Limited, London, UK, has
sent us the following correction of their voting rights notification dated
22 May 2013:

Threadneedle Asset Management Limited, London, UK, has notified us pursuant
to sec. 21 para. 1 WpHG, that on 18 April 2013 the share of voting rights
in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN: DE0007289001 went
above the threshold of 5% and that the percentage of voting rights on that
day amounted to 5.35% (628,462 voting rights). Threadneedle Asset
Management Limited has notified us that these voting rights of 5.35%
(628,462 voting rights) are attributable to Threadneedle Asset Management
Limited pursuant to sec. 22 para. 1 sent. 1 no. 6 WpHG.

The voting rights were attributed to Threadneedle Asset Management Limited
inter alia from Threadneedle Investment Funds ICVC, being a shareholder
holding 3% or more of the voting rights in STRATEC Biomedical AG.

08.10.2014 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---

Language: English
Company: STRATEC Biomedical AG
Gewerbestr. 37
75217 Birkenfeld
Germany
Internet: www.stratec.com

End of Announcement DGAP News-Service

---